Please assess the completion status of the following clinical trial:

Trial Title: Maintenance of Benefit With Atomoxetine Hydrochloride in Adolescents With ADHD

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients must have ADHD.~* Must be 13-16 years of age.~* Must be able to swallow capsules.~* Expected to achieve score of 70 or more on IQ test~* Willing and reliable to keep appts. for clinic visits and test~Exclusion Criteria:~* Treatment within last 30 days with a drug that has not received regulatory approval for any indication.~* Patients who weigh less than 40 kg or greater than 70 kg.~* Patients with documented history of Bipolar I or II disorder, or psychosis~* Patients with documented history of autism, asperger's syndrome or pervasive developmental disorder

- Gender: ALL
- Minimum Age: 13 Years
- Maximum Age: 16 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).